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Transcription factor-induced pluripotency is extremely inefficient and assumed to be stochastic. In a recent
Nature publication, Rais et al. show that depletion of the methyl-binding protein 3 yields reprogramming
efficiencies of up to 100%within days, suggesting that elimination of a single gene suffices to render reprog-
ramming a deterministic process.Mammalian development is a unidirec-
tional process whereby embryonic cells
become progressively restricted in poten-
tial, owing to the gradual remodeling
of epigenetic landscapes. Remarkably,
forced expression of key transcription
factors is sufficient to overcome these
epigenetic barriers and generate induced
pluripotent stem cells (iPSCs) from differ-
entiated cells, although at extremely low
efficiencies. (Takahashi and Yamanaka,
2006). iPSC technology is a powerful
tool to derive patient-specific stem cells
for the study and potential treatment of
diseases (Stadtfeld and Hochedlinger,
2010). In addition, iPSCs offer a unique
platform to dissect mechanisms underly-
ing cellular differentiation and induced re-
programming. A focus of many research
labs has therefore been to define barriers
that resist the induction of pluripotency
and result in low reprogramming effi-
ciency. In a recent publication in Nature,
Rais et al. report that the nucleosome re-
modeling and deacetylation (NuRD)
component, methyl-binding protein 3
(Mbd3), acts as a major roadblock during
the acquisition of pluripotency.
Reprogramming efficiencies are
routinely calculated by dividing the num-
ber of iPSC colonies obtained after a
defined period of factor expression (usu-
ally 1–3 weeks) by the number of input
cells. These measurements typically yield
frequencies ranging from 0.01%–5%, de-
pending on the cell type and reprogram-
ming system. Previous work by Hanna
and colleagues documented that clonal
somatic cell populations invariably pro-
duced iPSCs, albeit at different latencies,when given additional time to divide in
culture (up to 18 weeks) (Hanna et al.,
2009). These results were consistent
with a mathematical model that fits a sto-
chastic process and excluded the possi-
bility that low reprogramming efficiency
is a consequence of rare ‘‘elite’’ cells
that preferentially form iPSCs (Figure 1).
Moreover these observations raised the
fundamental question of whether mole-
cules could be identifiedwhosemanipula-
tion would convert iPSC induction into a
deterministic process.
Rais et al. (2013) approached this ques-
tion by studying the reversion of mouse
epiblast stem cells (EpiSCs) into embry-
onic stem cells (ESCs). EpiSCs represent
a developmentally advanced cell type
compared to ESCs, but spontaneously
revert into ESC-like cells under permissive
culture conditions (Bao et al., 2009). The
authors performed an siRNA screen for
epigenetic regulators whose knockdown
facilitated EpiSC reversion. Surprisingly,
depletion of just one gene, Mbd3,
enhanced EpiSC reversion dramatically,
endowing almost every cell with the
potential to give rise to ESC-like cells.
Moreover, Mbd3 knockdown increased
the conversion of primordial germ cells
(committed germ cells that normally pro-
duce oocyte or sperm) into pluripotent
stemcells, representing yet another spon-
taneous reprogramming paradigm. Most
strikingly, upon Mbd3 depletion, a vast
majority of mouse and human somatic
cells, such as fibroblasts and hemato-
poietic and neural cells, reprogrammed
following ectopic expression of the classic
reprogramming factors Oct4, Sox2, Klf4,Cell Stem Cell 1and c-Myc (OKSM). These efficiencies
were achieved by employing so-called
‘‘secondary cells’’ (Stadtfeld andHoched-
linger, 2010), which carry the reprogram-
ming transgenes in every cell, allowing ho-
mogeneous factor expression.
The authors then performed clonal
analysis of nascent iPSCs to assess
the impact of Mbd3 on the stochastic
nature of reprogramming. This analysis
confirmed the previous assertion that
OKSM-induced wild-type cells fit a sto-
chastic model of iPSC induction (Hanna
et al., 2009). However, the dynamics of
reprogramming for Mbd3 knockdown
cells were consistent with a deterministic
model (R2 > 0.9) (Figure 1). To support
this claim, the authors performed live-cell
imaging, documenting that an Oct4-GFP
reporter was synchronously activated
in nearly all emerging iPSC colonies.
Furthermore, examination of global gene
expression, histone modifications, and
DNA methylation patterns in bulk popula-
tions depleted for Mbd3 showed high
similarity with established iPSCs after
only 8 days of OKSM expression.
Of note, Mbd3 has previously been
identified as a barrier of reprogramming
during the study of bulk populations in-
fected with individual viruses expressing
OKSM (Luo et al., 2013). However, these
studies failed to report 100% reprogram-
ming efficiencies and did not comment
on the deterministic nature of iPSC for-
mation. This notion underscores the
importance of using ‘‘secondary cells’’
and clonal analysis to accurately mea-
sure reprogramming efficiencies. Conse-
quently, it is possible that other previously3, October 3, 2013 ª2013 Elsevier Inc. 379
Figure 1. Reprogramming Dynamics forMbd3 Knockout Cells Compared toWild-Type Cells
By day 7, nearly 100% of Mbd3 knockout cells have induced pluripotency following OKSM expression,
fitting a deterministic model. The dynamics of reprogramming in wild-type cells differ, suggesting a sto-
chastic model.
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programming may also render reprog-
ramming a deterministic process when
analyzed in the same fashion.
Mechanistically, Mbd3 associated with
OKSM when overexpressed in HEK293
cells, and ChIP-seq analysis demon-
strated that Mbd3 was ectopically bound
to OKSM target sites following induction
of the reprogramming factors in fibro-
blasts. Consistent with a repressive role
of Mbd3, the authors observed that DNA
is more euchromatic at Mbd3 targets
upon Mbd3 knockdown. Further, Mbd3
mutants that failed to bind OKSM were
less effective at inhibiting reprogramming.
Together, these data suggest that direct
interaction between Mbd3 and reprog-
ramming factors is requisite for its inhibi-
tory effect on reprogramming, supporting
a model whereby OKSM recruit Mbd3 to
target loci, which suppresses their activa-
tion (Figure 1). When Mbd3 is depleted or
entirely removed, reprogramming pro-
ceeds unimpeded and in a deterministic
manner.380 Cell Stem Cell 13, October 3, 2013 ª201In addition to providing a surprising
new twist to the field of reprogramming,
the authors’ results offer a powerful
tool to study mechanisms of cell fate
change in near-homogeneous popula-
tions. Assuming that Mbd3 knockdown
cells follow the same transitions as wild-
type cells (Buganim et al., 2012; Polo
et al., 2012), it should be possible to
define the precise sequence of transcrip-
tional and epigenetic events leading
to completely reprogrammed iPSCs. The
deterministic nature of reprogramming in
Mbd3-depleted cells may further facilitate
the capture of defined intermediate states
that have lost somatic identity before
acquiring pluripotency for scientific and
therapeutic purposes. It should also be
noted that the reprogramming of somatic
cells following Mbd3 depletion still takes
6 days, requiring several rounds of cell
division. This is in contrast with other
types of somatic cell reprogramming,
including nuclear transfer and cell fusion
between somatic cells and pluripotent
cells, which occur within 36–48 hr (Stadt-3 Elsevier Inc.feld and Hochedlinger, 2010). The syn-
chronous reprogramming system by
Hanna and colleagues should thus enable
screens to identify molecules that are
essential for or further accelerate iPSC
generation.
The findings by Rais et al. also raise a
number of questions. For example, it re-
mains to be determined whether Mbd3
limits reprogramming in the context of
alternative transcription factor cocktails
or chemicals; one might predict that
reprogramming factors that do not
physically bind to Mbd3 should facilitate
efficient and deterministic reprogram-
ming as well. Mbd3-depleted cells were
reprogrammed in media containing LIF
as well as inhibitors against the GSK3b
and MEK kinases, which differs from the
conditions previously used to determine
the stochasticity of reprogramming. It
will therefore be important to assess
whether GSK3b and MEK signal inhibition
are essential to induce deterministic
reprogramming. Another question is
whether the findings on reprogramming
mouse EpiSCs into ESCs are applicable
to human cells. Human ESCs resemble
mouse EpiSCs in their epigenetic profile
and growth factor requirements, but pre-
vious attempts to convert human ESCs
into a mouse ESC-like state have proven
difficult (Hanna et al., 2010). Because
Mbd3 depletion is sufficient to convert
mouse EpiSCs into ESCs, it is possible
that it may also endow human ESCs with
a developmental state similar to that of
mouse ESCs. From a practical stand-
point, it is desirable to determine whether
increased reprogramming kinetics and
efficiency can be achieved without
genetic modification. Given the lack of
small molecules against Mbd3, histone
deacetylase inhibitors may be attractive
targets (Huangfu et al., 2008).
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